News & Events

News & Events : Press Releases

September 16, 2014


WATERTOWN, Mass. – September 16, 2014 – FORMA Therapeutics announced today that Mary Wadlinger has been appointed to the position of Senior Vice President, Human Resources. Mary joins FORMA having 25 years of experience as a strategic human resources leader in biotechnology and global biopharmaceuticals as well as consumer and nonprofit organizations. For the past 11 years, Mary has served at Millennium Pharmaceuticals, Inc., a subsidiary of Takeda Pharmaceutical Company Limited, in Cambridge Mass., most recently as Vice President Human Resources.

“Creating a high-performing company not only relies on finding and hiring the best talent but also on ensuring an emphasis on nurturing, developing and rewarding people to deliver great things.”

“As a results-oriented business partner, Mary’s incredible aptitude for organizational learning and development as well as talent engagement represents an outstanding fit for FORMA,” said Steven Tregay, Ph.D., President and CEO, FORMA Therapeutics. “Mary’s expertise in developing people in a way that fosters a healthy company culture to deliver high performance is consistent with our ideals at FORMA.”

“FORMA has assembled a passionate team having a shared purpose to develop innovative therapies and change lives. Creating a high-performing company not only relies on finding and hiring the best talent but also on ensuring an emphasis on nurturing, developing and rewarding people to deliver great things,” said Mary Wadlinger. “I look forward to applying my background toward furthering FORMA’s positive employment brand and entrepreneurial can-do culture.”

Prior to joining FORMA, Mary Wadlinger held numerous human resource leadership positions at Millennium, where she oversaw the HR business partners and had responsibility as department head for employee engagement, learning & development, talent and performance management, succession planning, compensation, and benefits. Millennium is known for its strong culture and has been recognized in Fortune and The Boston Globe as a “Great Place to Work.” Before entering the biotech sector, Mary served as Vice President, Human Resources and Customer Relations for a consumer goods internet retailer and led process improvement and auditing for a retail holding company. Mary has served as a member of WOMEN Unlimited’s President Counsel, Executive Development Roundtable at Boston University, HR Leadership Forum, and other not-for-profit and HR organizations.


FORMA Therapeutics' scientists are passionate about discovering and developing medicines that will make a difference in oncology and other genetically driven therapeutic areas. The company's drug discovery engine drives screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis and protein-protein interactions. Deep biological insight across targets is combined with the company's chemistry expertise and integrated with a world class network of academic investigators, clinical experts and corporate partners to rapidly direct the creation of high quality, innovative drug candidates.

FORMA is headquartered in Watertown, MA near the epicenter of the Cambridge Life Sciences cluster, with additional chemistry operations in Branford, CT.

Join our conversation on Twitter @FORMAInc.

Media Contact

For FORMA Therapeutics
Kari Watson or Charles Liles, +1 781-235-3060 or
MacDougall Biomedical Communications